- Investing Ideas
- Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Eris Lifesciences
Market Cap: ₹184.0b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,328.20
7D
-2.2%
1Y
-24.9%
Alembic Pharmaceuticals
Market Cap: ₹161.5b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹821.75
7D
-1.1%
1Y
-15.7%
Dr. Reddy's Laboratories
Market Cap: ₹978.8b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,175.00
7D
-2.2%
1Y
-8.0%
Aurobindo Pharma
Market Cap: ₹932.9b
A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.
AUROPHARMA
₹1,621.30
7D
-0.05%
1Y
54.4%
Viyash Scientific
Market Cap: ₹120.6b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹276.25
7D
8.1%
1Y
57.5%